Friday, January 28, 2011

Lorcaserin: Weight Loss Medication for Diabetes 2

This is the first “really new” pill in many years for type 2 diabetes. This is the first that really helps with weight loss as well.

Lorcaserin Shows Statistically Significant Weight Loss in Patients With Diabetes on DiabetesHealth.com

Tuesday, January 18, 2011

Two Diseases in a Person are not Well Understood

Diseases such as diabetes often do not come alone. Often they result in a patient having to manage more than one disease at a time. Studies show patients are not prepared for this.

Friday, January 07, 2011

Weight Loss in Patients with Diabetes

This is the first “really new” pill in many years for type 2 diabetes. This is the first that really helps with weight loss as well.

Dr. Joe Prendergast

Lorcaserin Shows Statistically Significant Weight Loss in Patients With Diabetes
Jen Blackstock
Dec 28, 2010

Arena Pharmaceuticals and Eisai Inc. recently released results of a phase 3 clinical trial for lorcaserin, a weight-loss drug they are developing in partnership. The trial, called BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management- Diabetes Management), targeted patients with type 2 diabetes who are overweight or obese.

Read full article.

Wednesday, January 05, 2011

FDA Announces Recall of Abbott Glucose Test Strips

December 22, 2010

FDA Announces Recall of Abbott Glucose Test Strips

The U.S. Food and Drug Administration today announced that the agency is working with Abbott Diabetes Care to recall 359 different lots of glucose test strips that were sold between January and May 2010 and marketed under the following brand names:
  • Precision Xceed Pro
  • Precision Xtra
  • Medisense Optium
  • Optium, OptiumEZ
  • and ReliOn Ultima

These test strips may give falsely low blood glucose results, which can lead patients to try to raise their blood glucose when it is unnecessary, or to fail to treat elevated blood glucose due to a falsely low reading.

The FDA has provided specific recommendations for patients and healthcare professionals with regard to the recalled products. Additional information about this recall can be found at FDA announces recall of Abbott glucose test strips and Questions and Answers About the Abbott Glucose Test Strip Recall.

For more information, please contact Stephanie Kutler, Director of Government Affairs, at skutler@endo-society.org.